EIR Anika Therapeutics Dec 2003

Seth Mailhot FDA, Michael Sweeney FDA$595.00 - Available Now

FDA investigators audited the Anika Therapeutics - Bedford, MA, United States facility and issued inspectional observation (via FDA 483) on 01 Dec 2003.

Product details

  • Category:
  • Inspection end: 01 Dec 2003
  • Location: Bedford, United States
  • FEI: 1000148242
Add To Cart